Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 31 July 2026.

Series B
£33.2M

EQT Ventures led the Series B round, which will fund team expansion and product development.

"Unmind was built on the belief that everyone has the right to a healthy mind. Thanks to the support from our investors, this round of funding gives us the opportunity to scale our team while further developing the product with clinically-backed insights and research. In turn, this will help us to meet growing global demand from employers looking to drive positive cultural change around mental health in the workplace. At Unmind, we see the future of mental healthcare rooted in prevention. After all, we all have mental health, all of the time, and just like physical health or dental health, there’s a range of ways we can proactively nurture and improve it."
— Nick Taylor, Clinical Psychologist, Co-founder and CEO
Series B
£30.0M

The Series B round was led by Digital+ Partners with participation from HV Capital.

"With global freight reliability so low as a result of the pandemic, Brexit, and even the Suez Canal delays, it’s more important than ever for businesses to make informed supply-chain decisions that will enable them to serve and satisfy their customers, and Zencargo is the perfect partner to help them do that,"
— Alex Hersham, CEO
Series B
£3.0M

The Series B round was led by TMT Investments and values the fintech firm at £40m.

"As an operationally profitable bank challenger serving a distinct segment of the market, it was great to receive such strong and quick support from the VC’s. We service mid-market clients from over 190 countries, supporting their high-value international payments through our extended correspondent network; a market that is dramatically underserved by both the pure online players and big merchant banks."
— Ivan Zhiznevskiy, CEO
Series B
£35.9M

Koch Disruptive Technologies led the Series B round to support the commercialisation of the Veros diagnostics platform.

"This Series B round is crucial in providing us with the resources to grow our Veros platform to revolutionize decentralized point-of-care testing; and it is particularly important as we commercialize our Veros COVID-19 test, which delivers laboratory quality results directly to users within minutes, without an instrument. This will be an essential tool in the effective management of outbreaks of this and other diseases,"
— Harry Lamble, CEO